XPhyto Therapeutics Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was CAD 7,685 compared to negative sales of CAD 76,813 a year ago. Operating loss was CAD 3.992 million compared to CAD 3.493 million a year ago. Net loss was CAD 4.163 million compared to CAD 3.594 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.06 a year ago. For the half year, sales was CAD 11,383 compared to CAD 183,702 a year ago. Operating loss was CAD 9.196 million compared to CAD 7.162 million a year ago. Net loss was CAD 9.529 million compared to CAD 7.281 million a year ago. Basic loss per share from continuing operations was CAD 0.14 compared to CAD 0.13 a year ago.